Page 67 - product-manual
P. 67

TM/MC  TM/MC
             PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





        Boswellia serrata (Indian Frankincense)

        Boswellic acids, the major constituent of Gummi Boswellii, are thought to contribute to most
        of the herb’s pharmacological activities. Animal studies and clinical trials support the potential
        of Gummi Boswellii for the treatment of a variety of inflammatory diseases such as rheumatoid
        arthritis,  osteoarthritis,  inflammatory  bowel  disease,  and  asthma.  In  inflammatory  response,  the
        molecular targets of Gummi Boswellii are inhibition of microsomal prostaglandin E synthase-1,
        serine protease cathepsin G, and suppression of leukotriene  formation via inhibition  of 5-
        lipoxygenase  which  are  attributed  to  boswellic  acids  such  as  β-boswellic  acid,  11-keto-β-
        boswellic acid and acetyl-11-keto-β-boswellic acid (Safayhi et al., 1997; Siemoneit et al., 2009;
        Kunnumakkara et al., 2009; Abdel et al., 2011). In an open multi-centre veterinary clinical trial,
        administration of Gummi Boswellii (400 mg/10 kg of body weight/day) in dogs with chronic
        joint and spinal disease reduced the severity and resolution of clinical signs such as intermittent
        lameness, local pain and stiff gait in 6 weeks (Reichling et al., 2004).



                Toxicity for Gummi Boswellii has not been documented in dogs and cats when administered orally in therapeutic
            TOXICOLOGY  established at >2 g/kg of body weight (Singh & Atal, 1986).                   50
                doses. In toxicity studies of Gummi Boswellii extract in rats and mice, the oral and intraperitoneal LD  has been



                Equivalent toxic dose in 20 kg dog:   >40 g PO and IP of Gummi Boswellii extract.
                Equivalent toxic dose in 5 kg cat:
                                                 >10 g PO and IP of Gummi Boswellii extract.



                   DRUG     Validated interactions studies do not exist for Gummi Boswellii preparations. Clinical interactions
          INTERACTIONS      with other drugs have not been reported.







                                 Phyllanthus emblica (Indian Gooseberry)


                                 Fructus Phyllanthi, commonly known as Indian gooseberry or amla, is an important herbal
                                 drug used in Unani and Ayurvedic systems of medicine to treat various disorders including
                                 arthritis. Fructus Phyllanthi is highly nutritious and could be an important dietary source of
                                 vitamin C, amino acids, and minerals (Krishnaveni & Mirunalini, 2010). Fructus Phyllanthi has
                                 been found to induce a statistically significant chondroprotective activity in articular cartilage
                                 explants culture from osteoarthritis patients (Sumantran et al., 2008). Fructus Phyllanti also
                                 induces apoptosis of osteoclasts which can prevent joint destruction in rheumatoid arthritis
                                 (Penolazzi et al., 2008). It has been proposed that the immunomodulatory properties of the
                                 extracts  of  Fructus  Phyllanti  may  be  beneficial  in  the  management  of  rheumatoid  arthritis
                                 (Ganju et al., 2003).






        6  |   Articulare-VM TM
   62   63   64   65   66   67   68   69   70   71   72